PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.59%
Positive revenue growth while AR is negative. John Neff might see a notable competitive edge here.
7.03%
Positive gross profit growth while AR is negative. John Neff would see a clear operational edge over the competitor.
-152.91%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-152.91%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-305.00%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-306.17%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-306.17%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
-0.18%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-16.98%
Negative OCF growth while AR is at 7.56%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-21.43%
Negative FCF growth while AR is at 15.38%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
94.91%
10Y revenue/share CAGR under 50% of AR's 226.56%. Michael Burry would suspect a lasting competitive disadvantage.
-24.34%
Negative 5Y CAGR while AR stands at 76.73%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-62.20%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
198.22%
10Y OCF/share CAGR above 1.5x AR's 83.73%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-19.41%
Negative 5Y OCF/share CAGR while AR is at 266.41%. Joel Greenblatt would question the firm’s operational model or cost structure.
-44.64%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-444.10%
Negative 10Y net income/share CAGR while AR is at 196.15%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-145.86%
Negative 5Y net income/share CAGR while AR is 129.17%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-123.28%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
347.81%
10Y equity/share CAGR above 1.5x AR's 24.95%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
14.67%
5Y equity/share CAGR above 1.5x AR's 2.75%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
-27.59%
Negative 3Y equity/share growth while AR is at 31.02%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
956.80%
10Y dividend/share CAGR above 1.5x AR's 12.12%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
131.87%
Dividend/share CAGR of 131.87% while AR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
-50.07%
Negative near-term dividend growth while AR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
2.03%
Our AR growth while AR is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
100.00%
Inventory growth of 100.00% while AR is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
-2.16%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-1.54%
We have a declining book value while AR shows 1.35%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-6.57%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
137.21%
SG&A growth well above AR's 24.05%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.